ALTEPLASE

ALTEPLASE was reported 15038 times

These side effects are most commonly reported by patients taking ALTEPLASE:

# Side effect Count
0 NO ADVERSE EVENT 2541
1 OFF LABEL USE 1883
2 DEATH 1194
3 GINGIVAL BLEEDING 1031
4 CEREBRAL HAEMORRHAGE 827
5 HAEMORRHAGE INTRACRANIAL 741
6 DRUG INEFFECTIVE 646
7 ANGIOEDEMA 631
8 HAEMORRHAGE 577
9 HAEMORRHAGIC TRANSFORMATION STROKE 441
10 PRODUCT STORAGE ERROR 391
11 NAUSEA 372
12 DYSPNOEA 349
13 HYPOTENSION 347
14 VOMITING 345
15 PNEUMONIA 290
16 CHEST PAIN 270
17 INTERCEPTED PRODUCT STORAGE ERROR 264
18 HEADACHE 259
19 CEREBROVASCULAR ACCIDENT 248
20 PYREXIA 247
21 INTERCEPTED MEDICATION ERROR 244
22 CEREBRAL INFARCTION 218
23 PAIN 214
24 NEUROLOGICAL DECOMPENSATION 197
25 PULMONARY EMBOLISM 195
26 RESPIRATORY FAILURE 195
27 ISCHAEMIC STROKE 180
28 CARDIAC ARREST 175
29 INTENTIONAL PRODUCT USE ISSUE 172
30 FATIGUE 169
31 DRUG INTERACTION 166
32 HAEMATOMA 164
33 GASTROINTESTINAL HAEMORRHAGE 153
34 APLASTIC ANAEMIA 150
35 ANAEMIA 149
36 SWOLLEN TONGUE 149
37 BRADYCARDIA 147
38 ACUTE KIDNEY INJURY 141
39 SEPSIS 138
40 ASTHENIA 137
41 BRAIN OEDEMA 136
42 SUBARACHNOID HAEMORRHAGE 134
43 HYPERTENSION 133
44 BLOOD PRESSURE INCREASED 132
45 DIARRHOEA 132
46 PRODUCT QUALITY ISSUE 130
47 VENTRICULAR TACHYCARDIA 130
48 EPISTAXIS 129
49 MYOCARDIAL INFARCTION 126
50 CEREBRAL HAEMATOMA 125
51 DIZZINESS 124
52 MOUTH HAEMORRHAGE 124
53 VENTRICULAR EXTRASYSTOLES 123
54 FEBRILE NEUTROPENIA 122
55 COMA 121
56 HAEMOGLOBIN DECREASED 120
57 RASH 119
58 ATRIAL FIBRILLATION 118
59 DEEP VEIN THROMBOSIS 112
60 HYPERSENSITIVITY 110
61 HYPERHIDROSIS 108
62 THROMBOCYTOPENIA 106
63 BRAIN HERNIATION 105
64 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 105
65 CHEST DISCOMFORT 104
66 COUGH 104
67 MEDICATION ERROR 102
68 SEIZURE 102
69 HAEMATURIA 101
70 ANAPHYLACTIC REACTION 100
71 ABDOMINAL PAIN 99
72 CONDITION AGGRAVATED 97
73 HAEMORRHAGIC STROKE 94
74 PRURITUS 93
75 TACHYCARDIA 92
76 BLOOD PRESSURE DECREASED 91
77 HEMIPARESIS 89
78 LIP SWELLING 88
79 TONGUE HAEMORRHAGE 88
80 CONFUSIONAL STATE 87
81 ANXIETY 85
82 CARDIAC FAILURE 85
83 CARDIOGENIC SHOCK 84
84 BACK PAIN 83
85 APHASIA 81
86 BLOOD FIBRINOGEN DECREASED 80
87 PAIN IN EXTREMITY 79
88 HYPOXIA 78
89 ACUTE MYOCARDIAL INFARCTION 77
90 DYSPHAGIA 77
91 URTICARIA 77
92 VENTRICULAR FIBRILLATION 77
93 HAEMORRHAGIC INFARCTION 76
94 OXYGEN SATURATION DECREASED 76
95 THROMBOSIS 76
96 RENAL FAILURE 75
97 SEPTIC SHOCK 75
98 TONGUE OEDEMA 75
99 CARDIAC FAILURE CONGESTIVE 73
100 GENERAL PHYSICAL HEALTH DETERIORATION 73
101 MUCOSAL INFLAMMATION 73
102 DEPRESSED LEVEL OF CONSCIOUSNESS 72
103 DYSARTHRIA 71
104 ARRHYTHMIA 70
105 ARTHRALGIA 70
106 HAEMOPTYSIS 70
107 INTRAVENTRICULAR HAEMORRHAGE 70
108 PLATELET COUNT DECREASED 68
109 SHOCK 68
110 MUSCULAR WEAKNESS 67
111 PRODUCT PREPARATION ERROR 67
112 PULMONARY OEDEMA 67
113 HAEMATEMESIS 66
114 OEDEMA PERIPHERAL 66
115 PLEURAL EFFUSION 66
116 PNEUMONIA ASPIRATION 66
117 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 64
118 COAGULOPATHY 64
119 ERYTHEMA 64
120 RESPIRATORY DISTRESS 64
121 CHILLS 63
122 CYTOKINE RELEASE SYNDROME 63
123 PRODUCT CLOSURE ISSUE 63
124 INFECTION 62
125 SOMNOLENCE 62
126 TREATMENT FAILURE 62
127 CONSTIPATION 61
128 MALAISE 61
129 ECCHYMOSIS 59
130 EMBOLISM 59
131 ACUTE RESPIRATORY FAILURE 58
132 CARDIO-RESPIRATORY ARREST 58
133 HAEMORRHAGIC CEREBRAL INFARCTION 57
134 DECREASED APPETITE 56
135 FALL 56
136 NEUTROPENIA 56
137 PANCYTOPENIA 56
138 PRODUCT USE ISSUE 56
139 LOSS OF CONSCIOUSNESS 55
140 BLOOD CREATINE PHOSPHOKINASE INCREASED 54
141 HYPOAESTHESIA 54
142 OEDEMA 54
143 URINARY TRACT INFECTION 54
144 HEMIPLEGIA 53
145 NEUROPATHY PERIPHERAL 53
146 UPPER GASTROINTESTINAL HAEMORRHAGE 53
147 WEIGHT DECREASED 53
148 OVERDOSE 52
149 MENTAL STATUS CHANGES 51
150 COVID-19 50
151 INCORRECT PRODUCT STORAGE 50
152 BRAIN STEM HAEMORRHAGE 49
153 DEVICE ISSUE 49
154 DRUG HYPERSENSITIVITY 49
155 CEREBRAL ISCHAEMIA 48
156 DISEASE PROGRESSION 48
157 HAEMOTHORAX 48
158 PRODUCT TEMPERATURE EXCURSION ISSUE 48
159 FLUSHING 47
160 ENCEPHALOPATHY 46
161 MULTI-ORGAN FAILURE 46
162 HYPOKALAEMIA 45
163 INCORRECT DOSE ADMINISTERED 45
164 INTERNATIONAL NORMALISED RATIO INCREASED 45
165 HYDROCEPHALUS 44
166 PARAESTHESIA 44
167 DEHYDRATION 43
168 HEART RATE INCREASED 43
169 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43
170 SPEECH DISORDER 43
171 ANAPHYLACTIC SHOCK 42
172 EXTRAVASATION 42
173 UNRESPONSIVE TO STIMULI 42
174 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42
175 DEVICE OCCLUSION 41
176 LETHARGY 40
177 PRODUCT CONTAINER ISSUE 40
178 TACHYPNOEA 40
179 VITREOUS HAEMORRHAGE 40
180 COMPARTMENT SYNDROME 39
181 CONTUSION 39
182 INSOMNIA 39
183 PERICARDIAL EFFUSION 39
184 PERIPHERAL SWELLING 39
185 ALOPECIA 38
186 BLOOD CREATININE INCREASED 38
187 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 38
188 SINUS TACHYCARDIA 38
189 PRODUCT USE IN UNAPPROVED INDICATION 37
190 RENAL FAILURE ACUTE 37
191 STROKE IN EVOLUTION 37
192 AGITATION 36
193 EMBOLIC STROKE 36
194 INJECTION SITE EXTRAVASATION 36
195 RETINAL DETACHMENT 36
196 STOMATITIS 36
197 ABDOMINAL DISTENSION 35
198 CATHETER SITE HAEMORRHAGE 35
199 EXTRASYSTOLES 35
200 HAEMATOCRIT DECREASED 35
201 INFUSION RELATED REACTION 35
202 RENAL IMPAIRMENT 35
203 RESTLESSNESS 35
204 CONVULSION 34
205 DEVICE MALFUNCTION 34
206 DRUG ADMINISTRATION ERROR 34
207 DYSPHORIA 34
208 GAIT DISTURBANCE 34
209 HEPARIN-INDUCED THROMBOCYTOPENIA 34
210 PRODUCT COMPLAINT 34
211 RECTAL HAEMORRHAGE 34
212 SUBDURAL HAEMATOMA 34
213 CARDIAC TAMPONADE 33
214 HAEMORRHAGE SUBCUTANEOUS 33
215 PALLOR 33
216 TRANSFUSION 33
217 WHITE BLOOD CELL COUNT DECREASED 33
218 BACTERAEMIA 32
219 DEPRESSION 32
220 DRUG EFFECT DECREASED 32
221 PULMONARY HAEMORRHAGE 32
222 PULMONARY HYPERTENSION 32
223 RESPIRATORY ARREST 32
224 RETROPERITONEAL HAEMORRHAGE 32
225 STAPHYLOCOCCAL INFECTION 32
226 EMOTIONAL DISTRESS 31
227 INTRACRANIAL PRESSURE INCREASED 31
228 LARYNGEAL OEDEMA 31
229 RESPIRATORY DISORDER 31
230 ASCITES 30
231 ATELECTASIS 30
232 CYANOSIS 30
233 HEPATIC FAILURE 30
234 INFARCTION 30
235 LEUKOCYTOSIS 30
236 MATERNAL EXPOSURE DURING PREGNANCY 30
237 NERVOUS SYSTEM DISORDER 30
238 HAEMODYNAMIC INSTABILITY 29
239 HYPERGLYCAEMIA 29
240 MUSCLE SPASMS 29
241 PRODUCT DOSE OMISSION ISSUE 29
242 REPERFUSION ARRHYTHMIA 29
243 SWELLING FACE 29
244 TREMOR 29
245 ABDOMINAL PAIN UPPER 28
246 BRAIN MIDLINE SHIFT 28
247 CEREBRAL ARTERY OCCLUSION 28
248 CHRONIC KIDNEY DISEASE 28
249 DEVICE RELATED INFECTION 28
250 DISSEMINATED INTRAVASCULAR COAGULATION 28
251 NEUROTOXICITY 28
252 SINUS BRADYCARDIA 28
253 SWELLING 28
254 ALTERED STATE OF CONSCIOUSNESS 27
255 BASAL GANGLIA HAEMORRHAGE 27
256 BLOOD GLUCOSE INCREASED 27
257 NIH STROKE SCALE SCORE INCREASED 27
258 PERICARDIAL HAEMORRHAGE 27
259 VAGINAL HAEMORRHAGE 27
260 ACUTE RESPIRATORY DISTRESS SYNDROME 26
261 FACIAL PARALYSIS 26
262 ISCHAEMIA 26
263 PERIPHERAL ISCHAEMIA 26
264 PUNCTURE SITE HAEMORRHAGE 26
265 REOCCLUSION 26
266 RETINAL HAEMORRHAGE 26
267 SUBCUTANEOUS HAEMATOMA 26
268 VISION BLURRED 26
269 WEIGHT INCREASED 26
270 ANGINA PECTORIS 25
271 EPILEPSY 25
272 INTRAOCULAR PRESSURE INCREASED 25
273 MALIGNANT NEOPLASM PROGRESSION 25
274 METABOLIC ACIDOSIS 25
275 PHARYNGEAL OEDEMA 25
276 PULSELESS ELECTRICAL ACTIVITY 25
277 THROMBOLYSIS 25
278 TREATMENT DELAYED 25
279 WHEEZING 25
280 ALANINE AMINOTRANSFERASE INCREASED 24
281 CARDIAC DISORDER 24
282 COLITIS 24
283 DYSPNOEA EXERTIONAL 24
284 OBSTRUCTIVE AIRWAYS DISORDER 24
285 OROPHARYNGEAL PAIN 24
286 PALPITATIONS 24
287 VISUAL IMPAIRMENT 24
288 ASPARTATE AMINOTRANSFERASE INCREASED 23
289 INJURY 23
290 NEOPLASM MALIGNANT 23
291 PAIN IN JAW 23
292 SHOCK HAEMORRHAGIC 23
293 SINUSITIS 23
294 STRIDOR 23
295 WHITE BLOOD CELL COUNT INCREASED 23
296 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22
297 ARTERIOSCLEROSIS 22
298 BRAIN DEATH 22
299 DISCOMFORT 22
300 DYSPEPSIA 22
301 DYSPHONIA 22
302 MACULAR HOLE 22
303 NO THERAPEUTIC RESPONSE 22
304 PNEUMOTHORAX 22
305 UPPER RESPIRATORY TRACT INFECTION 22
306 AORTIC DISSECTION 21
307 ATRIOVENTRICULAR BLOCK COMPLETE 21
308 BLOOD POTASSIUM DECREASED 21
309 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21
310 CNS VENTRICULITIS 21
311 INFUSION SITE EXTRAVASATION 21
312 LIP OEDEMA 21
313 NEUTROPHIL COUNT DECREASED 21
314 PETECHIAE 21
315 SYNCOPE 21
316 VASCULAR PSEUDOANEURYSM 21
317 ACCIDENTAL EXPOSURE TO PRODUCT 20
318 BLOOD PRESSURE SYSTOLIC INCREASED 20
319 BRONCHOSPASM 20
320 CARDIAC VENTRICULAR THROMBOSIS 20
321 DELIRIUM 20
322 DRY SKIN 20
323 FIBRIN D DIMER INCREASED 20
324 GASTROOESOPHAGEAL REFLUX DISEASE 20
325 HOSPITALISATION 20
326 HYPOFIBRINOGENAEMIA 20
327 HYPONATRAEMIA 20
328 ILL-DEFINED DISORDER 20
329 MENTAL DISORDER 20
330 MYOCARDIAL ISCHAEMIA 20
331 TRANSIENT ISCHAEMIC ATTACK 20
332 ATRIAL FLUTTER 19
333 BRONCHITIS 19
334 CAROTID ARTERY OCCLUSION 19
335 FEELING ABNORMAL 19
336 HEPATIC FUNCTION ABNORMAL 19
337 INTRACARDIAC THROMBUS 19
338 POST PROCEDURAL HAEMORRHAGE 19
339 PRODUCTIVE COUGH 19
340 RETROPERITONEAL HAEMATOMA 19
341 RIGHT VENTRICULAR FAILURE 19
342 VENTRICULAR ARRHYTHMIA 19
343 ABDOMINAL WALL HAEMATOMA 18
344 BLOOD UREA INCREASED 18
345 CARDIOVASCULAR DISORDER 18
346 CEREBELLAR HAEMORRHAGE 18
347 COMPLICATION ASSOCIATED WITH DEVICE 18
348 ENDOTRACHEAL INTUBATION 18
349 HEART RATE DECREASED 18
350 HIATUS HERNIA 18
351 HYPOPHAGIA 18
352 MYALGIA 18
353 PROCEDURAL HAEMORRHAGE 18
354 PRODUCT PREPARATION ISSUE 18
355 THERAPEUTIC RESPONSE DECREASED 18
356 ASPIRATION 17
357 BLOOD ALKALINE PHOSPHATASE INCREASED 17
358 CELLULITIS 17
359 CEREBRAL HYPERPERFUSION SYNDROME 17
360 CEREBRAL MASS EFFECT 17
361 CONTRAINDICATED PRODUCT ADMINISTERED 17
362 COVID-19 PNEUMONIA 17
363 DYSURIA 17
364 FEELING HOT 17
365 HALLUCINATION 17
366 HYPERKALAEMIA 17
367 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 17
368 INTRA-ABDOMINAL HAEMORRHAGE 17
369 MOBILITY DECREASED 17
370 MUSCULOSKELETAL PAIN 17
371 NASOPHARYNGITIS 17
372 OSTEOPOROSIS 17
373 PARALYSIS 17
374 PERIPHERAL EMBOLISM 17
375 SUBDURAL HAEMORRHAGE 17
376 ACIDOSIS 16
377 APNOEA 16
378 BACTERIAL INFECTION 16
379 BLOOD BILIRUBIN INCREASED 16
380 CIRCULATORY COLLAPSE 16
381 HYPOPHOSPHATAEMIA 16
382 LACTIC ACIDOSIS 16
383 MELAENA 16
384 MEMORY IMPAIRMENT 16
385 MITRAL VALVE INCOMPETENCE 16
386 NECK PAIN 16
387 NEUROLOGICAL SYMPTOM 16
388 OSTEOARTHRITIS 16
389 PANCREATITIS 16
390 RED BLOOD CELL COUNT DECREASED 16
391 REPERFUSION INJURY 16
392 THERAPY NON-RESPONDER 16
393 VENOOCCLUSIVE LIVER DISEASE 16
394 ANGIOPATHY 15
395 BLOOD CALCIUM DECREASED 15
396 CEREBRAL ARTERY EMBOLISM 15
397 CLOSTRIDIUM DIFFICILE COLITIS 15
398 GASTROINTESTINAL DISORDER 15
399 HYPERNATRAEMIA 15
400 INTERCEPTED PRODUCT PREPARATION ERROR 15
401 LEG AMPUTATION 15
402 LIP HAEMORRHAGE 15
403 LYMPHOCYTE COUNT DECREASED 15
404 MYOCARDIAL RUPTURE 15
405 ORAL PAIN 15
406 OSTEOMYELITIS 15
407 POST PROCEDURAL COMPLICATION 15
408 PRODUCT ADMINISTRATION ERROR 15
409 RETINAL PIGMENT EPITHELIAL TEAR 15
410 SKIN DISCOLOURATION 15
411 SUPRAVENTRICULAR TACHYCARDIA 15
412 THROMBOSIS IN DEVICE 15
413 TUMOUR LYSIS SYNDROME 15
414 ACUTE MYELOID LEUKAEMIA 14
415 BLISTER 14
416 BONE DISORDER 14
417 BONE MARROW FAILURE 14
418 BURNING SENSATION 14
419 C-REACTIVE PROTEIN INCREASED 14
420 CARDIAC DEATH 14
421 CENTRAL NERVOUS SYSTEM LESION 14
422 DEVICE DISLOCATION 14
423 HAEMATOCHEZIA 14
424 ILLNESS 14
425 INCORRECT DRUG ADMINISTRATION RATE 14
426 PREGNANCY 14
427 PRESYNCOPE 14
428 PROTHROMBIN TIME PROLONGED 14
429 PULMONARY CONGESTION 14
430 RASH ERYTHEMATOUS 14
431 SKIN LACERATION 14
432 UNEVALUABLE EVENT 14
433 URINARY INCONTINENCE 14
434 URINARY RETENTION 14
435 URINE OUTPUT DECREASED 14
436 VENA CAVA THROMBOSIS 14
437 VENTRICULAR HYPOKINESIA 14
438 ABDOMINAL DISCOMFORT 13
439 ANAPHYLACTOID REACTION 13
440 AREFLEXIA 13
441 CATARACT 13
442 CEREBRAL DISORDER 13
443 COAGULATION TEST ABNORMAL 13
444 DEVICE LEAKAGE 13
445 EYE MOVEMENT DISORDER 13
446 FAILURE TO THRIVE 13
447 GASTRIC HAEMORRHAGE 13
448 GENERALISED OEDEMA 13
449 HEMIANOPIA 13
450 HYPERPHOSPHATAEMIA 13
451 INJECTION SITE PAIN 13
452 LIMB DISCOMFORT 13
453 LUNG DISORDER 13
454 MIGRAINE 13
455 OEDEMA MOUTH 13
456 PLATELET TRANSFUSION 13
457 PULSE ABSENT 13
458 RHINORRHOEA 13
459 RHYTHM IDIOVENTRICULAR 13
460 SPINAL CORD COMPRESSION 13
461 STATUS EPILEPTICUS 13
462 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13
463 UNDERDOSE 13
464 ANHEDONIA 12
465 AORTIC ANEURYSM RUPTURE 12
466 ATRIAL THROMBOSIS 12
467 BLOOD LACTATE DEHYDROGENASE INCREASED 12
468 BRAIN INJURY 12
469 CEREBROVASCULAR DISORDER 12
470 CLOSTRIDIUM DIFFICILE INFECTION 12
471 COMPLETED SUICIDE 12
472 CORONARY ARTERY DISEASE 12
473 DECUBITUS ULCER 12
474 DISEASE RECURRENCE 12
475 DISORIENTATION 12
476 EJECTION FRACTION DECREASED 12
477 ELECTROCARDIOGRAM QT PROLONGED 12
478 EYELID OEDEMA 12
479 GASTRITIS 12
480 GENERALISED TONIC-CLONIC SEIZURE 12
481 HYPERBILIRUBINAEMIA 12
482 HYPOVOLAEMIA 12
483 MALNUTRITION 12
484 MUSCLE HAEMORRHAGE 12
485 MUSCLE TWITCHING 12
486 OSTEONECROSIS OF JAW 12
487 PERITONITIS 12
488 PNEUMONITIS 12
489 POSTINFARCTION ANGINA 12
490 RALES 12
491 RASH PAPULAR 12
492 RENAL DISORDER 12
493 RESPIRATORY TRACT INFECTION 12
494 SUDDEN DEATH 12
495 SUPRAVENTRICULAR EXTRASYSTOLES 12
496 ABSCESS 11
497 ADENOVIRUS INFECTION 11
498 ANGINA UNSTABLE 11
499 ANURIA 11
500 ARTERIAL THROMBOSIS 11
501 ARTHRITIS 11
502 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11
503 BLINDNESS 11
504 BLOOD LOSS ANAEMIA 11
505 BODY TEMPERATURE INCREASED 11
506 CARDIAC FAILURE ACUTE 11
507 COGNITIVE DISORDER 11
508 COLD SWEAT 11
509 DRUG INTOLERANCE 11
510 ELECTROLYTE IMBALANCE 11
511 EMPYEMA 11
512 END STAGE RENAL DISEASE 11
513 EXTRADURAL HAEMATOMA 11
514 EXTRAVASATION BLOOD 11
515 FACE OEDEMA 11
516 GLAUCOMA 11
517 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11
518 HAEMORRHOIDS 11
519 HYPOCALCAEMIA 11
520 HYPOVOLAEMIC SHOCK 11
521 IMPAIRED HEALING 11
522 INJECTION SITE HAEMORRHAGE 11
523 INTRACRANIAL MASS 11
524 LIVIDITY 11
525 LOCAL SWELLING 11
526 LUNG INFECTION 11
527 LUNG INFILTRATION 11
528 MOVEMENT DISORDER 11
529 MUCOSAL HAEMORRHAGE 11
530 NEPHROGENIC SYSTEMIC FIBROSIS 11
531 NEURALGIA 11
532 PERIPHERAL ARTERY OCCLUSION 11
533 PERITONEAL HAEMORRHAGE 11
534 PLASMA CELL MYELOMA 11
535 PLEURITIC PAIN 11
536 PROCEDURAL COMPLICATION 11
537 SMALL INTESTINAL OBSTRUCTION 11
538 SPINAL OSTEOARTHRITIS 11
539 STAPHYLOCOCCAL BACTERAEMIA 11
540 TRICUSPID VALVE INCOMPETENCE 11
541 VENOOCCLUSIVE DISEASE 11
542 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 10
543 AMNESIA 10
544 AMPUTATION 10
545 ARTERIAL OCCLUSIVE DISEASE 10
546 ARTERY DISSECTION 10
547 ASTHMA 10
548 BLOOD ALBUMIN DECREASED 10
549 BONE PAIN 10
550 BRAIN STEM INFARCTION 10
551 CARDIOMEGALY 10
552 CEREBELLAR INFARCTION 10
553 CEREBRAL ARTERY THROMBOSIS 10
554 COLITIS ISCHAEMIC 10
555 ENCEPHALITIS 10
556 EXPIRED PRODUCT ADMINISTERED 10
557 FEELING COLD 10
558 FLUID OVERLOAD 10
559 GANGRENE 10
560 HAEMORRHAGE URINARY TRACT 10
561 HYPHAEMA 10
562 HYPOGLYCAEMIA 10
563 HYPOMAGNESAEMIA 10
564 INCORRECT ROUTE OF DRUG ADMINISTRATION 10
565 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10
566 INTERNAL HAEMORRHAGE 10
567 LIVER FUNCTION TEST ABNORMAL 10
568 NIH STROKE SCALE ABNORMAL 10
569 NODAL RHYTHM 10
570 PERICARDITIS 10
571 PERIPHERAL COLDNESS 10
572 PRODUCT CONTAMINATION 10
573 PRODUCT DISPENSING ERROR 10
574 RETCHING 10
575 SERUM FERRITIN INCREASED 10
576 SKIN DISORDER 10
577 SKIN HAEMORRHAGE 10
578 SPLENIC INFARCTION 10
579 STREPTOCOCCAL BACTERAEMIA 10
580 THROAT TIGHTNESS 10
581 ACUTE CORONARY SYNDROME 9
582 ACUTE PULMONARY OEDEMA 9
583 AGGRESSION 9
584 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 9
585 AMYLOIDOSIS 9
586 ANEURYSM 9
587 ATRIOVENTRICULAR BLOCK 9
588 BALANCE DISORDER 9
589 BLOOD PRESSURE SYSTOLIC DECREASED 9
590 CEREBRAL ATROPHY 9
591 CONJUNCTIVAL HYPERAEMIA 9
592 CYSTITIS 9
593 DISABILITY 9
594 EMBOLISM ARTERIAL 9
595 EMBOLISM VENOUS 9
596 EPSTEIN-BARR VIRUS INFECTION 9
597 FLANK PAIN 9
598 GASTRIC ULCER 9
599 GAZE PALSY 9
600 HEPATIC ENZYME INCREASED 9
601 HEPATOMEGALY 9
602 HIP FRACTURE 9
603 HYPERCAPNIA 9
604 INTENTIONAL PRODUCT MISUSE 9
605 INTESTINAL ISCHAEMIA 9
606 INTESTINAL OBSTRUCTION 9
607 INTRACRANIAL HAEMATOMA 9
608 JOINT CONTRACTURE 9
609 JOINT SWELLING 9
610 LABORATORY TEST ABNORMAL 9
611 LIVER DISORDER 9
612 MENINGITIS 9
613 METASTATIC NEOPLASM 9
614 MOTOR DYSFUNCTION 9
615 NASAL CONGESTION 9
616 NEPHROLITHIASIS 9
617 OLIGURIA 9
618 OSTEONECROSIS 9
619 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9
620 PHLEBITIS 9
621 PNEUMONIA BACTERIAL 9
622 POOR QUALITY PRODUCT ADMINISTERED 9
623 PROTEIN TOTAL DECREASED 9
624 PULMONARY MASS 9
625 RASH MACULAR 9
626 RENAL INFARCT 9
627 RESTRICTIVE CARDIOMYOPATHY 9
628 RHEGMATOGENOUS RETINAL DETACHMENT 9
629 SPLENIC RUPTURE 9
630 TENDERNESS 9
631 THALAMUS HAEMORRHAGE 9
632 TROPONIN INCREASED 9
633 UPPER-AIRWAY COUGH SYNDROME 9
634 VASCULAR OCCLUSION 9
635 VASOGENIC CEREBRAL OEDEMA 9
636 VIITH NERVE PARALYSIS 9
637 VISUAL ACUITY REDUCED 9
638 VITAMIN D DEFICIENCY 9
639 VOCAL CORD PARALYSIS 9
640 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9
641 ANEURYSM RUPTURED 8
642 APLASIA 8
643 BASILAR ARTERY OCCLUSION 8
644 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 8
645 BLOOD TRIGLYCERIDES INCREASED 8
646 BUNDLE BRANCH BLOCK RIGHT 8
647 CATHETER SITE HAEMATOMA 8
648 CENTRAL VENOUS CATHETERISATION 8
649 CEREBELLAR HAEMATOMA 8
650 CEREBRAL VENTRICLE DILATATION 8
651 CONJUNCTIVAL HAEMORRHAGE 8
652 CORONARY ARTERY OCCLUSION 8
653 CYTOPENIA 8
654 DEAFNESS 8
655 DERMATITIS CONTACT 8
656 DEVICE RELATED THROMBOSIS 8
657 DIABETES MELLITUS 8
658 DISTURBANCE IN ATTENTION 8
659 DRUG EXPOSURE DURING PREGNANCY 8
660 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8
661 ENDOCARDITIS 8
662 EXPOSURE DURING PREGNANCY 8
663 EXTREMITY NECROSIS 8
664 FRACTURE 8
665 GASTROENTERITIS 8
666 GINGIVITIS 8
667 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8
668 GRAND MAL CONVULSION 8
669 HAIR COLOUR CHANGES 8
670 HEAD INJURY 8
671 HEART TRANSPLANT 8
672 HYPERTRANSAMINASAEMIA 8
673 HYPOALBUMINAEMIA 8
674 INCISION SITE HAEMORRHAGE 8
675 INFECTIOUS PLEURAL EFFUSION 8
676 INFLUENZA 8
677 INJECTION SITE ERYTHEMA 8
678 INJECTION SITE HAEMATOMA 8
679 IRON DEFICIENCY ANAEMIA 8
680 ISCHAEMIC CEREBRAL INFARCTION 8
681 JOINT STIFFNESS 8
682 LEUKOPENIA 8
683 LIVEDO RETICULARIS 8
684 LOCALISED OEDEMA 8
685 LYMPHADENOPATHY 8
686 MADAROSIS 8
687 METHAEMOGLOBINAEMIA 8
688 MONOPARESIS 8
689 MUSCULOSKELETAL DISCOMFORT 8
690 MUSCULOSKELETAL DISORDER 8
691 MYDRIASIS 8
692 NEPHROGENIC ANAEMIA 8
693 NEUTROPHIL COUNT INCREASED 8
694 OSTEOPENIA 8
695 PARENTERAL NUTRITION 8
696 PARESIS 8
697 PATHOLOGICAL FRACTURE 8
698 PRODUCT LEAKAGE 8
699 PUPILLARY REFLEX IMPAIRED 8
700 QUADRIPLEGIA 8
701 RASH MACULO-PAPULAR 8
702 RENAL INJURY 8
703 RESPIRATORY RATE INCREASED 8
704 SCAR 8
705 SINUS DISORDER 8
706 SKIN ABRASION 8
707 SKIN TIGHTNESS 8
708 SLEEP APNOEA SYNDROME 8
709 TOXICITY TO VARIOUS AGENTS 8
710 VESSEL PUNCTURE SITE HAEMATOMA 8
711 ADRENAL INSUFFICIENCY 7
712 ASPHYXIA 7
713 ATAXIA 7
714 BASAL GANGLIA INFARCTION 7
715 BLINDNESS UNILATERAL 7
716 BLOOD PHOSPHORUS DECREASED 7
717 BONE LESION 7
718 BRADYARRHYTHMIA 7
719 BULLOUS HAEMORRHAGIC DERMATOSIS 7
720 CARDIOPULMONARY FAILURE 7
721 CAROTID ARTERY DISSECTION 7
722 CEREBRAL REPERFUSION INJURY 7
723 CEREBRAL THROMBOSIS 7
724 CONGESTIVE CARDIOMYOPATHY 7
725 CONJUNCTIVITIS 7
726 CORONARY ARTERY BYPASS 7
727 DEFORMITY 7
728 DIPLOPIA 7
729 DYSKINESIA 7
730 EMOTIONAL DISORDER 7
731 EYE PAIN 7
732 FIBRINOLYSIS INCREASED 7
733 FLUID RETENTION 7
734 GRAFT VERSUS HOST DISEASE 7
735 HAEMOLYSIS 7
736 HAEMORRHAGIC DIATHESIS 7
737 HAIR DISORDER 7
738 HAIR TEXTURE ABNORMAL 7
739 HERPES SIMPLEX VIRAEMIA 7
740 HOT FLUSH 7
741 HYPERCALCAEMIA 7
742 HYPERCHOLESTEROLAEMIA 7
743 HYPERCOAGULATION 7
744 HYPERLIPIDAEMIA 7
745 HYPERTENSIVE CRISIS 7
746 HYPERTHERMIA 7
747 HYPOTHYROIDISM 7
748 HYPOTONIA 7
749 INFLAMMATION 7
750 INJECTION SITE VESICLES 7
751 LIVER INJURY 7
752 LOWER GASTROINTESTINAL HAEMORRHAGE 7
753 MUSCULOSKELETAL CHEST PAIN 7
754 NEPHROPATHY TOXIC 7
755 NEUTROPENIC COLITIS 7
756 NEUTROPENIC SEPSIS 7
757 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7
758 PHARYNGEAL HAEMORRHAGE 7
759 PLATELET COUNT INCREASED 7
760 PNEUMONIA FUNGAL 7
761 POLYNEUROPATHY 7
762 PRODUCT PACKAGING ISSUE 7
763 PULMONARY ARTERIAL HYPERTENSION 7
764 PULMONARY FIBROSIS 7
765 PUPIL FIXED 7
766 PURULENT DISCHARGE 7
767 RENAL TUBULAR NECROSIS 7
768 RESPIRATORY DEPRESSION 7
769 RESTLESS LEGS SYNDROME 7
770 SENSORY LOSS 7
771 SKIN EXFOLIATION 7
772 SKIN LESION 7
773 SKIN ULCER 7
774 STRESS CARDIOMYOPATHY 7
775 SURGERY 7
776 THERAPY PARTIAL RESPONDER 7
777 THROMBECTOMY 7
778 TOOTH LOSS 7
779 ULCER 7
780 UROGENITAL HAEMORRHAGE 7
781 UROSEPSIS 7
782 VASCULAR GRAFT 7
783 VASOSPASM 7
784 VENOUS THROMBOSIS 7
785 VERTEBRAL ARTERY DISSECTION 7
786 VIRAL INFECTION 7
787 WRONG DRUG ADMINISTERED 7
788 WRONG PRODUCT ADMINISTERED 7
789 ADMINISTRATION SITE EXTRAVASATION 6
790 ADVERSE DRUG REACTION 6
791 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6
792 AORTIC ANEURYSM 6
793 AORTIC ARTERIOSCLEROSIS 6
794 BLOOD FIBRINOGEN INCREASED 6
795 BLOOD PRESSURE ABNORMAL 6
796 BLOOD PRESSURE FLUCTUATION 6
797 BLOOD PRESSURE IMMEASURABLE 6
798 BLOOD SODIUM DECREASED 6
799 BLOOD URINE PRESENT 6
800 BRAIN COMPRESSION 6
801 CANDIDA INFECTION 6
802 CARBON DIOXIDE DECREASED 6
803 CARDIOMYOPATHY 6
804 CAROTID ARTERY STENOSIS 6
805 CAROTID ARTERY THROMBOSIS 6
806 CHEST WALL HAEMATOMA 6
807 CHOLELITHIASIS 6
808 CLONUS 6
809 COAGULATION TIME PROLONGED 6
810 COMPRESSION FRACTURE 6
811 CORONARY ARTERY THROMBOSIS 6
812 DEVICE FAILURE 6
813 DIVERTICULITIS 6
814 ELECTROCARDIOGRAM ABNORMAL 6
815 ELECTROMECHANICAL DISSOCIATION 6
816 ESCHERICHIA BACTERAEMIA 6
817 EXTRA DOSE ADMINISTERED 6
818 EYE SWELLING 6
819 FEEDING DISORDER 6
820 FEMUR FRACTURE 6
821 FIBROSIS 6
822 GLOSSODYNIA 6
823 HAEMOGLOBINURIA 6
824 HAEMOLYTIC ANAEMIA 6
825 HAEMOPERITONEUM 6
826 HEPATOCELLULAR INJURY 6
827 HERPES ZOSTER 6
828 HICCUPS 6
829 HYPOACUSIS 6
830 HYPOAESTHESIA ORAL 6
831 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6
832 ILEUS 6
833 IMPAIRED QUALITY OF LIFE 6
834 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6
835 INJECTION SITE OEDEMA 6
836 IRRITABILITY 6
837 JOINT RANGE OF MOTION DECREASED 6
838 JUGULAR VEIN THROMBOSIS 6
839 LEFT VENTRICULAR DYSFUNCTION 6
840 LEFT VENTRICULAR FAILURE 6
841 LOOSE TOOTH 6
842 MENTAL IMPAIRMENT 6
843 METASTASES TO BONE 6
844 METASTASES TO LIVER 6
845 MUSCLE ATROPHY 6
846 MUSCLE TIGHTNESS 6
847 MUSCULOSKELETAL STIFFNESS 6
848 MYASTHENIA GRAVIS 6
849 MYOCLONUS 6
850 NEOPLASM PROGRESSION 6
851 NIGHT SWEATS 6
852 OBESITY 6
853 OCCULT BLOOD POSITIVE 6
854 ODYNOPHAGIA 6
855 OXYGEN SATURATION ABNORMAL 6
856 PARAPLEGIA 6
857 PELVIC VENOUS THROMBOSIS 6
858 PERIPHERAL ARTERY THROMBOSIS 6
859 POOR VENOUS ACCESS 6
860 PRODUCT RECONSTITUTION QUALITY ISSUE 6
861 PSYCHOLOGICAL TRAUMA 6
862 PSYCHOTIC DISORDER 6
863 PULMONARY FUNCTION TEST DECREASED 6
864 PURPURA 6
865 QUADRIPARESIS 6
866 RASH PRURITIC 6
867 RED CELL DISTRIBUTION WIDTH INCREASED 6
868 RENAL FAILURE CHRONIC 6
869 RENAL VEIN THROMBOSIS 6
870 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6
871 RHABDOMYOLYSIS 6
872 SECOND PRIMARY MALIGNANCY 6
873 SENSATION OF FOREIGN BODY 6
874 SKIN FISSURES 6
875 SKIN HYPERPIGMENTATION 6
876 SKIN WARM 6
877 STEVENS-JOHNSON SYNDROME 6
878 TEMPERATURE INTOLERANCE 6
879 THERAPY INTERRUPTED 6
880 TONGUE HAEMATOMA 6
881 TOOTH ABSCESS 6
882 TRANSAMINASES INCREASED 6
883 TUMOUR HAEMORRHAGE 6
884 VENOUS OCCLUSION 6
885 WOUND 6
886 ABDOMINAL ABSCESS 5
887 ABNORMAL BEHAVIOUR 5
888 ABORTION 5
889 ACCELERATED IDIOVENTRICULAR RHYTHM 5
890 AGRANULOCYTOSIS 5
891 ANAPHYLACTOID SHOCK 5
892 AORTIC THROMBOSIS 5
893 APALLIC SYNDROME 5
894 BLEEDING TIME PROLONGED 5
895 BLOOD BRAIN BARRIER DEFECT 5
896 BLOOD LACTIC ACID INCREASED 5
897 BLOOD POTASSIUM INCREASED 5
898 BLOOD PRESSURE DIASTOLIC INCREASED 5
899 BLOOD UREA DECREASED 5
900 BRAIN NATRIURETIC PEPTIDE INCREASED 5
901 BRAIN STEM SYNDROME 5
902 BREAST CANCER 5
903 BREATH SOUNDS ABNORMAL 5
904 BRONCHOPULMONARY ASPERGILLOSIS 5
905 CARDIAC MURMUR 5
906 CATHETER SITE SWELLING 5
907 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 5
908 CEREBRAL AMYLOID ANGIOPATHY 5
909 CHOLECYSTITIS 5
910 CHROMATURIA 5
911 CIRCUMORAL OEDEMA 5
912 CONSCIOUSNESS FLUCTUATING 5
913 CONTRAINDICATION TO MEDICAL TREATMENT 5
914 CORONARY ARTERY STENOSIS 5
915 CORONARY REVASCULARISATION 5
916 CRANIAL NERVE DISORDER 5
917 DEMENTIA 5
918 DERMATITIS ALLERGIC 5
919 DERMATITIS BULLOUS 5
920 DEVICE DEFECTIVE 5
921 DILATATION VENTRICULAR 5
922 DRY MOUTH 5
923 ECONOMIC PROBLEM 5
924 ELECTROENCEPHALOGRAM ABNORMAL 5
925 ENDOPHTHALMITIS 5
926 ENDOTRACHEAL INTUBATION COMPLICATION 5
927 ENTEROCOCCAL BACTERAEMIA 5
928 EOSINOPHILIA 5
929 FEAR 5
930 FIBRINOLYSIS 5
931 FOETAL EXPOSURE DURING PREGNANCY 5
932 FURUNCLE 5
933 GAIT INABILITY 5
934 HAEMATOMA MUSCLE 5
935 HAEMODIALYSIS 5
936 HEMIANOPIA HOMONYMOUS 5
937 HEPATIC CIRRHOSIS 5
938 HYPERAEMIA 5
939 HYPERCHLORAEMIA 5
940 HYPERPARATHYROIDISM SECONDARY 5
941 HYPERPYREXIA 5
942 HYPERVOLAEMIA 5
943 HYPOGONADISM 5
944 IMMUNODEFICIENCY 5
945 IMMUNOSUPPRESSION 5
946 INFLUENZA LIKE ILLNESS 5
947 INFUSION SITE ERYTHEMA 5
948 INFUSION SITE HAEMORRHAGE 5
949 INFUSION SITE PAIN 5
950 INFUSION SITE SWELLING 5
951 INJECTION SITE INFECTION 5
952 INTERLEUKIN LEVEL INCREASED 5
953 INTERNATIONAL NORMALISED RATIO ABNORMAL 5
954 INTERNATIONAL NORMALISED RATIO DECREASED 5
955 INTERSTITIAL LUNG DISEASE 5
956 INTERVERTEBRAL DISC DEGENERATION 5
957 INTESTINAL INFARCTION 5
958 INTRACRANIAL VENOUS SINUS THROMBOSIS 5
959 ISCHAEMIC HEPATITIS 5
960 KLEBSIELLA INFECTION 5
961 KLEBSIELLA SEPSIS 5
962 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5
963 LIVER FUNCTION TEST INCREASED 5
964 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5
965 LOWER RESPIRATORY TRACT INFECTION 5
966 LUMBAR SPINAL STENOSIS 5
967 LUNG CONSOLIDATION 5
968 LUNG NEOPLASM MALIGNANT 5
969 METASTASES TO CENTRAL NERVOUS SYSTEM 5
970 METASTASES TO SPINE 5
971 MOUTH SWELLING 5
972 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5
973 NYSTAGMUS 5
974 OCULAR HYPERAEMIA 5
975 ORAL DISCOMFORT 5
976 ORAL DISORDER 5
977 ORGANISING PNEUMONIA 5
978 PARTIAL SEIZURES 5
979 PERFORATION 5
980 PERIPHERAL SENSORY NEUROPATHY 5
981 POLYURIA 5
982 PORTAL HYPERTENSION 5
983 POST THROMBOTIC SYNDROME 5
984 POTENTIATING DRUG INTERACTION 5
985 PRIMARY SEQUESTRUM 5
986 PRODUCT DOSE OMISSION 5
987 PRODUCT NAME CONFUSION 5
988 PROSTHETIC CARDIAC VALVE THROMBOSIS 5
989 PRURITUS GENERALISED 5
990 PULMONARY ARTERY THROMBOSIS 5
991 RADICULOPATHY 5
992 SARS-COV-2 TEST POSITIVE 5
993 SENSORY DISTURBANCE 5
994 SKIN INDURATION 5
995 SLEEP DISORDER 5
996 SPUTUM DISCOLOURED 5
997 SPUTUM INCREASED 5
998 STAPHYLOCOCCAL SEPSIS 5
999 SYSTEMIC LUPUS ERYTHEMATOSUS 5